TL;DR
This study identifies five key proteases in chicken embryos that activate Newcastle Disease Virus (NDV) by cleaving its fusion (F) protein. Understanding these proteases reveals why some NDV strains are too dangerous for in ovo (in the egg) vaccination and offers a new strategy for developing safer, more effective vaccines delivered before hatching.
What Problem Does This Paper Address?
In ovo vaccination is a promising method to immunize chickens before they hatch, offering early protection and streamlining the vaccination process. However, many live NDV vaccine strains, safe for post-hatch use, are too virulent for in ovo administration, causing embryo death. The underlying mechanism for this increased pathogenicity in embryos has been poorly understood. Previous work suggested that the F protein cleavage site (FCS) of NDV plays a crucial role, with a specific three-basic-amino-acid FCS (3B-FCS) leading to attenuation. This paper aims to identify the specific host proteases responsible for cleaving NDV's F protein in chicken embryos and to elucidate how these proteases contribute to viral pathogenicity and tissue tropism.
Methods
The researchers employed a multi-pronged approach:
- RNA Sequencing (RNA-seq): To identify the repertoire of trypsin-like serine proteases expressed in different chicken embryo tissues (lung, liver, muscle).
- Reverse Transcription Quantitative PCR (RT-qPCR): To confirm the expression levels of candidate proteases in various tissues.
- Cell Culture and Viral Replication Assays: Using DF1 cells (a chicken embryo fibroblast cell line) and primary chicken embryo cells (lung, liver, muscle) to test the ability of identified proteases to activate NDV replication.
- Transient Expression Assays: Transfecting DF1 cells with plasmids encoding candidate proteases to assess their effect on NDV infection.
- Western Blotting: To detect F protein cleavage and expression of viral proteins.
- Fluorescence Microscopy and Flow Cytometry: To visualize viral infection and protease expression.
- In Vitro Cleavage Assays: Using synthesized FCS peptides to directly test the cleavage activity of identified proteases.
- Protease Inhibitor Studies: Using aprotinin and camostat to block protease activity and observe the effects on viral replication and pathogenicity.
- Recombinant NDV Construction: Engineering a modified NDV strain to express one of the identified proteases (Tmprss9) to study its impact on viral characteristics.
- Pathogenicity and Tissue Tropism Studies: Evaluating the survival rates, viral titers in various tissues, and histopathological lesions in chicken embryos inoculated with different NDV strains and/or protease inhibitors.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Protease-Dependent Pathogenicity: The study strongly suggests that the pathogenicity of NDV in chicken embryos is not solely determined by the viral FCS but is critically dependent on the presence and activity of specific embryonic proteases.
- Differential Protease Activation: Different NDV FCSs (2B-FCS vs. 3B-FCS) are activated by distinct sets of embryonic proteases, leading to varying degrees of viral replication and tissue tropism.
- Key Proteases Identified: Five trypsin-like proteases (Tmprss4, Tmprss9, F7, Prss23, and Cfd) were identified as crucial for NDV F protein cleavage in chicken embryos.
- Tissue-Specific Protease Distribution: The distribution of these proteases varies across embryonic tissues, with some (like Cfd and Prss23) being widely expressed and contributing significantly to broad tissue tropism and high pathogenicity.
- Implications for In Ovo Vaccines: The findings provide a molecular basis for why certain NDV strains are unsafe for in ovo vaccination and offer a rational design strategy for developing attenuated vaccines by manipulating the FCS or incorporating protease inhibitors.
Key Results
- Pathogenicity Correlation: NDV strains with a 2B-FCS showed high pathogenicity and broad tissue tropism in chicken embryos, while the strain with a 3B-FCS (TS09-C) exhibited low pathogenicity and limited tropism.
- Protease Identification: Five trypsin-like proteases (Tmprss4, Tmprss9, F7, Prss23, and Cfd) were identified as capable of cleaving NDV's F protein.
- Differential Cleavage: Tmprss4, Tmprss9, and F7 could cleave both 2B-FCS and 3B-FCS, while Prss23 and Cfd primarily cleaved the 2B-FCS.
- Protease Inhibitor Efficacy: Adding protease inhibitors (aprotinin and camostat) significantly reduced the pathogenicity and replication of NDV with 2B-FCS in chicken embryos and primary cells.
- Engineered NDV: A recombinant NDV expressing Tmprss9 (rTS-SS9) showed increased pathogenicity and tissue tropism compared to the parental strain, demonstrating the direct role of this protease.
- Histopathology: Histopathological lesions were observed in embryos infected with pathogenic NDV strains or the engineered rTS-SS9, correlating with viral replication and tissue damage.
Limitations and Future Work
- In Vitro vs. In Vivo: While in vitro and cell culture experiments provided strong evidence, the complex interplay of proteases and viral replication in vivo can be more nuanced.
- Protease Specificity: The study focused on trypsin-like proteases. Other protease families might also play a role in NDV pathogenesis.
- Future Vaccine Design: The authors propose that future in ovo NDV vaccines could be rationally designed by:
- Modifying the F protein cleavage site to be less susceptible to common embryonic proteases.
- Incorporating protease inhibitors into the vaccine formulation.
- Engineering NDV strains to express specific proteases that attenuate their pathogenicity.
- Broader Applicability: Further research could explore whether these identified proteases and mechanisms are relevant for other paramyxoviruses or viral pathogens that rely on protease-mediated F protein activation.
Summary updated